Medi-Cal phases DME and clinical-lab ordering NPI requirements into February and May 2027
Oct 18, 2026 edition · GC-2026-0420 · Published 2026-10-18 · Version 1 · Final
DME and clinical-laboratory claims require a valid individual ordering NPI from February 1, 2027. The ordering provider must be actively enrolled in Medi-Cal by May 1. The announcement preserves specified DME replacement-code exceptions and requires a separate referring NPI when otherwise applicable.
What happened
DHCS’s October 16 notice says DME and clinical-laboratory providers must include a 10-digit ordering-provider NPI on applicable Medi-Cal claim types effective February 1, 2027. The identifier must be an individual Type 1 NPI on NPPES, rather than a group NPI, and valid for the billed service date. DHCS identifies missing, invalid, inactive, absent or wrong-type identifiers as grounds for denial. The notice separately requires the ordering NPI to be actively enrolled as a participating Medi-Cal provider by May 1, 2027.
DME claims for HCPCS E1340, K0739, K0740, V5014, X2996 and X2998 with replacement modifier RP or RB are exempt from the ordering-provider-number requirement described in the notice. Where a referring NPI is also required, both ordering and referring identifiers belong in their respective fields. DHCS points to PAVE for enrollment and says updated manual sections will follow. The February claim-field requirement and May participation requirement are distinct phases; the notice does not move both duties to May.
Scope and timing
- Authority status
- Final
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- California
- Affected functions
- Revenue Cycle, Provider Enrollment
- Responsible owner
- Revenue Cycle
- Recorded date
- 2027-02-01
- Date type
- effective
Why it matters
Combining the two dates or dropping the specific code-and-modifier exception can produce incorrect front-end edits, avoidable denials or an incomplete provider-enrollment worklist.
Recommended action
Suggested internal action: Revenue Cycle and Provider Enrollment should maintain separate February 1 and May 1 implementation worklists, validate ordering NPIs as individual identifiers, test each of the six listed DME codes with replacement modifier RP or RB, and preserve separate referring fields where required. Confirm later manual guidance before extending the exception to other codes or modifiers.
Implementation playbook
- Test applicable ordering/referring fields and exact replacement-code exceptions before February 1; suggested internal preparation. Revenue Cycle
- Identify ordering providers needing active Medi-Cal participation by May 1, 2027; suggested worklist supporting the stated official requirement. Provider Enrollment · Due 2027-05-01
Sources
- Ordering, Referring and Prescribing: NPI Requirements for DME and Clinical Laboratory ProvidersOfficial · DHCS / Medi-Cal Providers · 2026-10-16
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →